Cartalax
Research profile · How we handle evidence
Cartalax is a peptide complex discussed as a support tool for cartilage health and joint function, with the goal of improving comfort and mobility in joint-focused protocols.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Daily
Half-life
Plasma elimination
Route
Subcutaneous
Safety Tier
Limited data
Overview
Cartalax is a peptide complex used in protocols aimed at cartilage support and joint function. The idea is to support the cartilage matrix and tissue maintenance rather than only addressing symptoms. It’s often discussed as a gene-expression–focused bioregulator approach, so people typically expect changes over weeks, not days.
Mechanism of Action
Cartalax is a peptide complex used in protocols aimed at cartilage support and joint function. The idea is to support the cartilage matrix and tissue maintenance rather than only addressing symptoms. It’s often discussed as a gene-expression–focused bioregulator approach, so people typically expect changes over weeks, not days.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Joint support
- Cartilage health
- Pain reduction
- Improved mobility
Side Effects
- Generally well-tolerated
Contraindications
- Pregnant or breastfeeding women
Structure & Sequence
Verified structure
Cartalax
Sequence illustration backed by PubChem match.
- Amino Acid Sequence
- Ala-Glu-Asp (AED)
- Molecular Weight
- 333.29 Da
- Chemical Formula
- C12H19N3O8
- CAS Number
- N/A
- Reconstituted pH
- 3.6
- InChIKey
- KXEVYGKATAMXJJ-ACZMJKKPSA-N
Stack & Route Context
Stacks with
- BPC-157
- TB-500
Administration
Subcutaneous
Research Status
Research peptide for joint health
Approval Status
Preclinical
Sports Legal
Permitted
References
- 1View source
Cartalax peptide overview (limited human evidence)
2026
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.